Indian Government Caps Trade Margins on Non-Scheduled Anti-Cancer Drugs at 30%

PravdaReport ·
Russia

The Indian government has moved to curb the cost of life-saving medications by capping trade margins for all non-scheduled anti-cancer drugs at 30% of the Maximum Retail Price (MRP), official sources told ANI on Thursday. This regulatory intervention targets the intermediaries in the pharmaceutical supply chain-wholesalers and retailers-limiting the profit percentage they can earn on…

Read original article on PravdaReport →

Related news